TCL Archive Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities June 22, 2012
TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive “Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says September 25, 1998
